Detailed Information on Publication Record
2022
Substituted propanamides as inhibitors of nucleases
PARUCH, Kamil, Benoit Jean-Pierre CARBAIN, Štěpán HAVEL, Vít VŠIANSKÝ, Fedor NIKULENKOV et. al.Basic information
Original name
Substituted propanamides as inhibitors of nucleases
Authors
PARUCH, Kamil (203 Czech Republic, belonging to the institution), Benoit Jean-Pierre CARBAIN (250 France, belonging to the institution), Štěpán HAVEL (203 Czech Republic, belonging to the institution), Vít VŠIANSKÝ (203 Czech Republic, belonging to the institution), Fedor NIKULENKOV (203 Czech Republic, belonging to the institution) and Lumír KREJČÍ (203 Czech Republic, belonging to the institution)
Edition
Number: AU2019256672, Publisher: IP Australia, Place of publication: Woden ACT, Owner's name: Masarykova univerzita, 2022
Other information
Language
English
Type of outcome
Patent
Field of Study
10401 Organic chemistry
Country of publisher
Australia
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
RIV identification code
RIV/00216224:14310/22:00134802
Organization unit
Faculty of Science
Keywords in English
DNA; propanamide; nuclease
Tags
Tags
International impact
Změněno: 6/8/2024 10:40, Mgr. Marie Šípková, DiS.
Abstract
V originále
Compounds represented by the structural formula (1) where R1, R2, R3, R4, R5, R6 are inhibitors of nucleases, and are useful in particular in a method of treatment and/or prevention of proliferative diseases, neurodegenerative diseases, and other genomic instability associated diseases.
Links
EF16_025/0007381, research and development project |
| ||
LM2018130, research and development project |
|